| Controlled release of 5-fluorouracil from microporous zeolites M Spanakis, N Bouropoulos, D Theodoropoulos, L Sygellou, S Ewart, ... Nanomedicine: Nanotechnology, Biology and Medicine 10 (1), 197-205, 2014 | 58 | 2014 |
| Potential drug–drug interactions in prescriptions dispensed in community pharmacies in Greece A Chatsisvili, I Sapounidis, G Pavlidou, E Zoumpouridou, VA Karakousis, ... Pharmacy world & science 32 (2), 187-193, 2010 | 47 | 2010 |
| Simultaneous determination of the flavonoid aglycones diosmetin and hesperetin in human plasma and urine by a validated GC/MS method: in vivo metabolic … M Spanakis, S Kasmas, I Niopas Biomedical Chromatography 23 (2), 124-131, 2009 | 45 | 2009 |
| Development and validation of a high performance liquid chromatographic method for the determination of oxcarbazepine and its main metabolites in human plasma and cerebrospinal … V Kimiskidis, M Spanakis, I Niopas, D Kazis, C Gabrieli, FI Kanaze, ... Journal of pharmaceutical and biomedical analysis 43 (2), 763-768, 2007 | 44 | 2007 |
| A validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in biological … M Spanakis, IS Vizirianakis, I Mironidou-Tzouvelekib, Maria, Niopas Biomed. Chromatogr 23, 1131-1137, 2009 | 20 | 2009 |
| Determination of atenolol in human plasma by HPLC with fluorescence detection: Validation and application in a pharmacokinetic study M Spanakis, I Niopas Journal of chromatographic science 51 (2), 128-132, 2013 | 18 | 2013 |
| Pharmacokinetic interaction between losartan and Rhodiola rosea in rabbits M Spanakis, IS Vizirianakis, G Batzias, I Niopas Pharmacology 91 (1-2), 112-116, 2013 | 17 | 2013 |
| Designing a digital patient avatar in the context of the MyHealthAvatar project initiative E Maniadi, H Kondylakis, EG Spanakis, M Spanakis, M Tsiknakis, ... 13th IEEE international conference on BioInformatics and BioEngineering, 1-4, 2013 | 13 | 2013 |
| Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery C Karavasili, M Spanakis, D Papagiannopoulou, IS Vizirianakis, ... Journal of pharmaceutical sciences 104 (7), 2304-2311, 2015 | 12 | 2015 |
| Secure access to patient's health records using SpeechXRays a mutli-channel biometrics platform for user authentication EG Spanakis, M Spanakis, A Karantanas, K Marias 2016 38th Annual International Conference of the IEEE Engineering in …, 2016 | 11 | 2016 |
| Enabling personalized cancer medicine decisions: the challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics IS Vizirianakis, GA Mystridis, K Avgoustakis, DG Fatouros, M Spanakis Oncology reports 35 (4), 1891-1904, 2016 | 9 | 2016 |
| GC–MS Simultaneous determination of enalapril and enalaprilat in human plasma: Application to a clinical pharmacokinetic study M Spanakis, I Niopas Chromatographia 72 (9-10), 957-962, 2010 | 8 | 2010 |
| Clinical and pharmacogenomic assessment of herb-drug interactions to improve drug delivery and pharmacovigilance SI Vizirianakis, M Spanakis, A Termentzi, I Niopas, E Kokkalou Plants in traditional and modern medicine: chemistry and activity, 978-81, 2010 | 8 | 2010 |
| ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF I Triviai, S Zeschke, J Rentel, M Spanakis, T Scherer, R Gabdoulline, ... Leukemia 33 (1), 99-109, 2019 | 5 | 2019 |
| In silico evaluation of gadofosveset pharmacokinetics in different population groups using the Simcyp® simulator platform M Spanakis, K Marias In silico pharmacology 2 (1), 2, 2014 | 4 | 2014 |
| Exploitation of patient avatars towards stratified medicine through the development of in silico clinical trials approaches M Spanakis, E Papadaki, D Kafetzopoulos, A Karantanas, TG Maris, ... 13th IEEE International Conference on BioInformatics and BioEngineering, 1-4, 2013 | 4 | 2013 |
| PDCA: An eHealth service for the management of drug interactions with complementary and alternative medicines M Spanakis, S Sfakianakis, EG Spanakis, G Kallergis, V Sakkalis 2018 IEEE EMBS International Conference on Biomedical & Health Informatics …, 2018 | 3 | 2018 |
| Assessment of DCE–MRI parameters for brain tumors through implementation of physiologically–based pharmacokinetic model approaches for Gd-DOTA M Spanakis, E Kontopodis, S Van Cauter, V Sakkalis, K Marias Journal of pharmacokinetics and pharmacodynamics 43 (5), 529-547, 2016 | 3 | 2016 |
| Addressing drug-drug and drug-food interactions through personalized empowerment services for healthcare M Spanakis, EG Spanakis, H Kondylakis, S Sfakianakis, I Genitsaridi, ... 2016 38th Annual International Conference of the IEEE Engineering in …, 2016 | 3 | 2016 |
| GC-MS Analysis of Volatile Constituents of Cornus mas Fruits and Pulp C Bakirtzi, P Tsatalas, M Spanakis, E Kokkalou Journal of Essential Oil Bearing Plants 16 (2), 183-200, 2013 | 3 | 2013 |
Ioannis NiopasProfessor of Clinical Pharmacy and Pharmacokinetics, School of Pharmacy, Aristotle University of ThessalonikiVerified email at pharm.auth.gr
